Estimation of Public Health Impact with Use of Nirsevimab During the 2024–2025 RSV Season in the USA: a Modeling Study.
Saved in:
| Title: | Estimation of Public Health Impact with Use of Nirsevimab During the 2024–2025 RSV Season in the USA: a Modeling Study. |
|---|---|
| Authors: | Yarnoff, Benjamin1 (AUTHOR) benjamin.yarnoff@thermofisher.com, Neary, Maureen P.2 (AUTHOR), Gabriel, Veronica2 (AUTHOR), Ghemmouri, Mehdi3 (AUTHOR), Hodges, Erin N.2 (AUTHOR), Tribaldos, Maribel2 (AUTHOR), Geurtsen, Jeroen4 (AUTHOR), Chit, Ayman2,5 (AUTHOR), Beuvelet, Matthieu3 (AUTHOR), Soudani, Samira3 (AUTHOR), Musci, Robert1 (AUTHOR), Krilov, Leonard R.6 (AUTHOR) |
| Source: | Pulmonary Therapy. Jun2026, Vol. 12 Issue 2, p707-720. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23641746 |
|---|---|
| DOI: | 10.1007/s41030-026-00348-z |
